Also known as: Peptic Ulcer Disease (Gastric and Duodenal Ulcers)
Peptic ulcers are open sores on the stomach lining or upper small intestine.
Peptic ulcer disease (PUD) refers to the development of open sores (ulcers) in the lining of the stomach (gastric ulcers) or the first part of the small intestine called the duodenum (duodenal ulcers). These ulcers form when the protective mucus layer that shields the digestive tract lining from stomach acid is compromised, allowing acid to erode the underlying tissue. Peptic ulcers affect millions of people worldwide and, while their incidence has declined with improved H. pylori treatment, they remain a significant cause of abdominal pain and gastrointestinal complications.
The two most common causes of peptic ulcers are infection with the bacterium Helicobacter pylori and prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, and aspirin. Contrary to popular belief, spicy foods and stress do not cause ulcers, although they can aggravate existing ones. H. pylori weakens the mucous coating by colonizing the stomach lining, while NSAIDs inhibit the production of prostaglandins that help maintain the mucosal barrier. Rarely, ulcers can result from Zollinger-Ellison syndrome, a condition that causes excessive acid production.
Most peptic ulcers can be successfully treated with medication, including proton pump inhibitors to reduce acid and antibiotics to eradicate H. pylori when present. Without treatment, ulcers can lead to serious complications including bleeding, perforation of the stomach or duodenal wall, and gastric outlet obstruction. Early diagnosis and appropriate management are essential for preventing these potentially life-threatening outcomes.
People with Peptic Ulcer often experience the following symptoms.
The hallmark symptom is a burning or gnawing pain in the upper middle abdomen, typically occurring between meals or during the night when the stomach is empty. The pain may last minutes to hours and is often temporarily relieved by eating or taking antacids.
Ulcer-related inflammation can impair normal gastric motility, leading to sensations of bloating, excessive fullness, and inability to consume normal meal volumes. This symptom can contribute to reduced food intake.
Gastric ulcers may disrupt the lower esophageal sphincter function or increase acid sensitivity, leading to heartburn. This overlap with GERD symptoms can sometimes make differential diagnosis challenging.
Nausea is common, particularly with gastric ulcers. Vomiting may occur and can provide temporary relief from pain. Persistent vomiting, especially of old food, may indicate gastric outlet obstruction from chronic ulceration.
A bleeding ulcer may cause vomiting of bright red blood or dark, coffee-ground-like material. This is a medical emergency requiring immediate evaluation and intervention to control the hemorrhage.
Blood from an upper gastrointestinal ulcer is digested as it passes through the intestines, producing black, tarry, foul-smelling stools. This indicates significant bleeding and warrants urgent medical attention.
Chronic ulcer pain associated with eating may cause patients to eat less, leading to gradual weight loss. Additionally, nausea and early satiety reduce caloric intake over time.
Duodenal ulcer patients may experience increased appetite because eating temporarily relieves pain (hunger pain pattern), while gastric ulcer patients may develop food aversion due to pain worsening after meals.
Certain factors may increase your likelihood of developing Peptic Ulcer.
Common approaches to managing peptic ulcer. Always consult a healthcare provider for personalized treatment.
When H. pylori is identified, standard triple therapy (PPI plus two antibiotics for 14 days) or bismuth quadruple therapy is prescribed. Successful eradication dramatically reduces ulcer recurrence rates from approximately 60-80 percent to less than 5 percent per year.
PPIs such as omeprazole, esomeprazole, and pantoprazole are the cornerstone of ulcer healing. They suppress gastric acid production by up to 99 percent, creating an optimal environment for mucosal repair. Treatment duration is typically 4-8 weeks for gastric ulcers and 2-4 weeks for duodenal ulcers.
Sucralfate forms a protective barrier over the ulcer base, shielding it from acid and pepsin. Misoprostol, a prostaglandin analog, is used specifically to prevent NSAID-induced ulcers in patients who require ongoing anti-inflammatory therapy.
Stopping the offending NSAID is crucial for ulcer healing. When anti-inflammatory therapy cannot be discontinued, switching to a COX-2 selective inhibitor with concurrent PPI use offers lower ulcer risk while maintaining pain management.
For bleeding ulcers, therapeutic endoscopy is performed using techniques such as thermal coagulation, hemoclip placement, or injection of epinephrine to achieve hemostasis. This is combined with high-dose intravenous PPI therapy for optimal outcomes.
Surgical intervention is reserved for complications that cannot be managed endoscopically, including uncontrolled hemorrhage, perforation, or gastric outlet obstruction. Procedures may include oversewing of bleeding vessels, ulcer excision, or vagotomy to reduce acid secretion.
Peptic ulcer disease is definitively diagnosed by upper gastrointestinal endoscopy (esophagogastroduodenoscopy or EGD), which allows direct visualization of the ulcer, assessment of its size and characteristics, biopsy of the ulcer margins to rule out malignancy (particularly for gastric ulcers), and testing for H. pylori through rapid urease testing or histology. All patients with peptic ulcer disease should be tested for H. pylori using at least one reliable method. Non-invasive H. pylori tests include the urea breath test and stool antigen test, both of which have high sensitivity and specificity. Blood tests including complete blood count assess for anemia from chronic bleeding. In cases where endoscopy is not immediately available, an upper GI barium series can provide preliminary information, though it is less sensitive than endoscopy and does not allow biopsy.
Steps that may help reduce the risk of developing or worsening peptic ulcer.
Avoid or minimize the use of NSAIDs; when they are necessary, use the lowest effective dose for the shortest duration and always take them with food.
If long-term NSAID use is required, take a concurrent proton pump inhibitor for gastroprotection as recommended by your physician.
Test for and treat H. pylori infection, especially if you have a history of ulcers or live in a region with high prevalence of the bacterium.
Limit alcohol consumption and quit smoking, as both impair mucosal defenses and slow ulcer healing.
Manage stress effectively through exercise, relaxation techniques, and adequate sleep, as while stress does not cause ulcers, it can exacerbate symptoms and delay healing.
If left untreated or poorly managed, peptic ulcer may lead to:
Some ulcers may temporarily improve, but without addressing the underlying cause (H. pylori infection or NSAID use), they are very likely to recur and may progress to serious complications. Proper medical treatment with acid suppression and, when indicated, antibiotic therapy is essential for complete healing and prevention of recurrence.
No. Spicy foods do not cause peptic ulcers. The primary causes are H. pylori infection and NSAID use. However, spicy foods can irritate an existing ulcer and worsen symptoms. During active ulcer treatment, it is advisable to avoid foods that cause discomfort, but there is no need to permanently eliminate spicy foods from the diet once the ulcer has healed.
Signs of a bleeding ulcer include vomiting blood (which may appear bright red or look like dark coffee grounds), passing black tarry stools (melena), feeling lightheaded or faint, and unexplained fatigue or pallor from anemia. If you experience any of these symptoms, seek immediate medical attention as bleeding ulcers can be life-threatening.
Yes, ulcers can recur, particularly if the underlying cause is not fully addressed. After successful H. pylori eradication, the annual recurrence rate drops to below 5 percent. However, if H. pylori is not eradicated or if NSAID use continues without protection, recurrence rates can exceed 60 percent within a year. Follow-up testing to confirm H. pylori eradication is recommended.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.